In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

It's not uncommon to experience side effects in the first few weeks of taking a new antidepressant. Here's what to look out ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T ... hepatic insufficiency, and stimulant drug abuse contribute to the risk for developing these arrhythmias, as do ...

39 Ebrahim et al 30 identified 185 eligible meta-analyses assessing the effects of different antidepressants, and in the meta-analyses including an author who was an employee of the manufacturer of ...

Both drugs were given on top of standard antidepressants ... the company will look to the new data to try to encourage take-up. One issue has been the cost of the drug, with health technology ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA ... is under investigation as an antidepressant for the treatment of major depressive ...

The mechanism of action underlying ketamine’s rapid antidepressant effects in patients with depression, both suffering from major depressive disorder (MDD) and bipolar disorder (BD), including ...

Psychiatrist Joanna Moncrieff indicts her entire industry for falsely pushing deadly drugs as a “treatment” for depression.

Medications enhancing dopaminergic tone include amantadine, bupropion, and stimulants, with yohimbine showing noradrenergic effects. Among the reported antidotes, the only 2 without ...

The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...